NO964333D0 - Intranasal antimigrenesammensetning - Google Patents

Intranasal antimigrenesammensetning

Info

Publication number
NO964333D0
NO964333D0 NO964333A NO964333A NO964333D0 NO 964333 D0 NO964333 D0 NO 964333D0 NO 964333 A NO964333 A NO 964333A NO 964333 A NO964333 A NO 964333A NO 964333 D0 NO964333 D0 NO 964333D0
Authority
NO
Norway
Prior art keywords
composition
antimigraine
intranasal
spray device
nasal spray
Prior art date
Application number
NO964333A
Other languages
English (en)
Other versions
NO310276B1 (no
NO964333L (no
Inventor
Marc Karel Jozef Francois
Roger Carolus August Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO964333D0 publication Critical patent/NO964333D0/no
Publication of NO964333L publication Critical patent/NO964333L/no
Publication of NO310276B1 publication Critical patent/NO310276B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19964333A 1994-04-13 1996-10-11 Intranasal antimigrenesammensetning NO310276B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (3)

Publication Number Publication Date
NO964333D0 true NO964333D0 (no) 1996-10-11
NO964333L NO964333L (no) 1996-10-11
NO310276B1 NO310276B1 (no) 2001-06-18

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964333A NO310276B1 (no) 1994-04-13 1996-10-11 Intranasal antimigrenesammensetning

Country Status (23)

Country Link
EP (1) EP0755253B1 (no)
JP (1) JP2921988B2 (no)
KR (1) KR100219952B1 (no)
CN (1) CN1146151A (no)
AT (1) ATE194915T1 (no)
AU (1) AU684360B2 (no)
BG (1) BG62197B1 (no)
BR (1) BR9507369A (no)
CA (1) CA2184822C (no)
CZ (1) CZ286610B6 (no)
DE (1) DE69518149T2 (no)
FI (1) FI118295B (no)
HR (1) HRP950149A2 (no)
HU (1) HU219495B (no)
IL (1) IL113341A (no)
NO (1) NO310276B1 (no)
NZ (1) NZ284454A (no)
PL (1) PL179761B1 (no)
RO (1) RO115414B1 (no)
SI (1) SI9500121A (no)
SK (1) SK129896A3 (no)
WO (1) WO1995028158A1 (no)
ZA (1) ZA953038B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
ATE194915T1 (de) 2000-08-15
JP2921988B2 (ja) 1999-07-19
HU9602806D0 (en) 1996-11-28
WO1995028158A1 (en) 1995-10-26
AU2305495A (en) 1995-11-10
CA2184822C (en) 2000-12-19
RO115414B1 (ro) 2000-02-28
JPH09505606A (ja) 1997-06-03
CZ286610B6 (cs) 2000-05-17
NO310276B1 (no) 2001-06-18
SI9500121A (en) 1995-10-31
HU219495B (hu) 2001-04-28
SK129896A3 (en) 1997-05-07
EP0755253A1 (en) 1997-01-29
FI964095A (fi) 1996-10-11
KR100219952B1 (ko) 1999-09-01
HRP950149A2 (en) 1997-06-30
NO964333L (no) 1996-10-11
PL179761B1 (pl) 2000-10-31
DE69518149D1 (de) 2000-08-31
IL113341A (en) 2000-08-31
PL316756A1 (en) 1997-02-03
CN1146151A (zh) 1997-03-26
HUT75939A (en) 1997-05-28
FI118295B (fi) 2007-09-28
BR9507369A (pt) 1997-09-23
EP0755253B1 (en) 2000-07-26
ZA953038B (en) 1996-10-14
CZ292096A3 (en) 1997-02-12
IL113341A0 (en) 1995-07-31
AU684360B2 (en) 1997-12-11
BG100889A (en) 1997-07-31
BG62197B1 (bg) 1999-05-31
CA2184822A1 (en) 1995-10-26
FI964095A0 (fi) 1996-10-11
NZ284454A (en) 1997-12-19
DE69518149T2 (de) 2001-03-22

Similar Documents

Publication Publication Date Title
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
MY113733A (en) Salts of an anti-migraine indole derivative
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
MX9601360A (es) Mezcla estabilizante sinergistica.
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
BR0108871A (pt) Composto, processo de preparação de compostos, e, composição farmacêutica
YU7804A (sh) Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
ATE194915T1 (de) Intranasales antimigränemittel
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
IL126199A0 (en) Nasal pharmaceutical composition for the treatment of delayed emesis
MX9604690A (es) Composicion antimigraña intranasal.
MX9603348A (es) Derivados de disulfuro de amida indano-2-mercaptoacetilica novedosos utiles como inhibidores de encefalinasa.
MX9701764A (es) Derivados de imidoacidos.
WO2002070069A3 (fr) Utilisation d'un ou plusieurs shogaol(s) en tant qu'aphrodisiaque
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
ES2170377T3 (es) Composicion que contiene quitosana.
MX9702486A (es) La fabricacion de levobupivacaina y sus analogos de l-lisina.
IL122537A0 (en) Arylalkoxyphenoxy-imidazoline compounds process for their preparation and pharmaceutical compositions containing them
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
RO116896B1 (ro) Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora
MX9703869A (es) Benzamida enterocinetica.
SE9704835D0 (sv) New compound

Legal Events

Date Code Title Description
MK1K Patent expired